I’d be interested if anyone has access/subscription to resources like Ibisworld to see if there’s stats or figures on sleep apnoea diagnosis market to give us a rough guide on what SleepCheck could be worth to RAP in US.
Even if we worked off a small percentage of the market, it’s got to have raised the value and prospects of the company in the IER.
I’d be interested if anyone has access/subscription to resources...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #